Rare disease news

FDA approvals, research breakthroughs, clinical trials, and advocacy updates

Curated and summarized by AI for patients and caregivers

🔍
AllDrug approvalsClinical trialsResearchGrants & fundingAdvocacy & policyPipeline
Show:All newsBreaking onlyImportant & breaking
Date:7 days30 days90 daysAll time

2 articles from the last 90 days matching "drug development"

PolicyRSS4 days ago

FDA Achieves Year 1 Goals in Reducing Animal Testing in Drug Development

The FDA announced it has completed its first year of goals to reduce the use of animals in drug testing. The agency launched several new programs to replace animal testing with alternative methods that are often faster and more accurate. This shift means new medicines can be developed and tested in ways that don't require testing on animals.

WHY IT MATTERSFaster, more reliable drug testing methods could accelerate the development and approval of treatments for rare diseases, potentially bringing new therapies to patients years sooner than traditional animal testing timelines allow.
ℹ Good to knowRead →
PolicyRSSApr 3

FDA Releases Draft Guidance on Alternatives to Animal Testing in Drug Development

The FDA released new guidelines to help drug companies test medicines using human-based methods instead of animal testing. These new testing approaches could make it faster and safer to develop drugs by using data that better reflects how humans respond. This is part of the FDA's effort to bring effective treatments to patients more quickly.

WHY IT MATTERSPatients with rare diseases could gain access to new treatments faster if drug developers can use these human-centered testing methods instead of spending years on animal studies.
ℹ Good to knowRead →

Get personalized rare disease news

Follow your conditions to see news about the diseases that matter to you — FDA approvals, trial openings, and research breakthroughs.

Create free account →Browse diseases